Article

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer

2019-05-31

Abstract excerpt

<h4>ABSTRACT</h4> Despite decreased screening-based detection of clinically insignificant tumors, most diagnosed prostate cancers are still indolent, indicating a need for better strategies for detection of clinically significant disease prior to treatment. We hypothesized that patients with detectable circulating tumor DNA (ctDNA) were more likely to harbor aggressive disease. We applied ultra-low pass whole gen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e75c6ee2-be9c-5de5-bffd-0af4f309e77f
DOI: 10.1101/655506

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Low Abundance of Circulating Tumor DNA in Localized Prostate CancerDOI 10.1101/655506Read

Low Abundance of Circulating Tumor DNA in Localized Prostate CancerSemantic proximity Read

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesisSemantic proximity Read

Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented testSemantic proximity Read

Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.Semantic proximity Read

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesisSemantic proximity Read

Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancerSemantic proximity Read

Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.Semantic proximity Read

High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer.Semantic proximity Read

Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretationSemantic proximity Read

Circulating tumor cells capture disease evolution in advanced prostate cancer.Semantic proximity Read

Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progressionSemantic proximity Read

Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.Semantic proximity Read